nodes	percent_of_prediction	percent_of_DWPC	metapath
Cisplatin—Platinum-containing Compounds—Carboplatin—uterine cancer	0.441	1	CiPCiCtD
Cisplatin—germ cell cancer—uterine cancer	0.193	1	CtDrD
Cisplatin—SLC31A2—Carboplatin—uterine cancer	0.0286	0.104	CbGbCtD
Cisplatin—MT2A—Carboplatin—uterine cancer	0.0206	0.0753	CbGbCtD
Cisplatin—ATP7A—Carboplatin—uterine cancer	0.0206	0.0753	CbGbCtD
Cisplatin—MT1A—Carboplatin—uterine cancer	0.0206	0.0753	CbGbCtD
Cisplatin—ATP7B—Carboplatin—uterine cancer	0.0206	0.0753	CbGbCtD
Cisplatin—SOD1—Carboplatin—uterine cancer	0.0164	0.0598	CbGbCtD
Cisplatin—SLC31A1—Carboplatin—uterine cancer	0.0164	0.0598	CbGbCtD
Cisplatin—GSTT1—Carboplatin—uterine cancer	0.0137	0.0501	CbGbCtD
Cisplatin—GSTM1—Carboplatin—uterine cancer	0.0119	0.0433	CbGbCtD
Cisplatin—ABCC6—Dactinomycin—uterine cancer	0.0117	0.0428	CbGbCtD
Cisplatin—GSTT1—Etoposide—uterine cancer	0.0115	0.042	CbGbCtD
Cisplatin—NQO1—Carboplatin—uterine cancer	0.00942	0.0344	CbGbCtD
Cisplatin—GSTP1—Carboplatin—uterine cancer	0.00857	0.0313	CbGbCtD
Cisplatin—GSTP1—Etoposide—uterine cancer	0.0072	0.0263	CbGbCtD
Cisplatin—ABCC6—Etoposide—uterine cancer	0.00662	0.0241	CbGbCtD
Cisplatin—NQO1—Doxorubicin—uterine cancer	0.00539	0.0197	CbGbCtD
Cisplatin—MPO—Carboplatin—uterine cancer	0.00492	0.018	CbGbCtD
Cisplatin—XDH—Carboplatin—uterine cancer	0.00492	0.018	CbGbCtD
Cisplatin—ABCC6—Doxorubicin—uterine cancer	0.00451	0.0165	CbGbCtD
Cisplatin—SLC22A2—Progesterone—uterine cancer	0.00395	0.0144	CbGbCtD
Cisplatin—ABCC3—Etoposide—uterine cancer	0.00318	0.0116	CbGbCtD
Cisplatin—XDH—Doxorubicin—uterine cancer	0.00282	0.0103	CbGbCtD
Cisplatin—ABCG2—Dactinomycin—uterine cancer	0.00231	0.00844	CbGbCtD
Cisplatin—ABCC3—Doxorubicin—uterine cancer	0.00217	0.00791	CbGbCtD
Cisplatin—ABCC2—Carboplatin—uterine cancer	0.00172	0.00628	CbGbCtD
Cisplatin—CYP2C9—Medroxyprogesterone Acetate—uterine cancer	0.00164	0.00597	CbGbCtD
Cisplatin—ABCG2—Carboplatin—uterine cancer	0.00156	0.00567	CbGbCtD
Cisplatin—ABCC2—Etoposide—uterine cancer	0.00144	0.00527	CbGbCtD
Cisplatin—PTGS2—Etoposide—uterine cancer	0.00143	0.00521	CbGbCtD
Cisplatin—ABCG2—Etoposide—uterine cancer	0.00131	0.00476	CbGbCtD
Cisplatin—CYP2C9—Progesterone—uterine cancer	0.00108	0.00396	CbGbCtD
Cisplatin—ABCB1—Progesterone—uterine cancer	0.00105	0.00384	CbGbCtD
Cisplatin—ABCC2—Doxorubicin—uterine cancer	0.000985	0.00359	CbGbCtD
Cisplatin—ABCG2—Doxorubicin—uterine cancer	0.000891	0.00325	CbGbCtD
Cisplatin—ABCB1—Dactinomycin—uterine cancer	0.000835	0.00304	CbGbCtD
Cisplatin—SLC31A2—exocrine gland—uterine cancer	0.00074	0.0283	CbGeAlD
Cisplatin—ABCC6—Podofilox—Etoposide—uterine cancer	0.000669	1	CbGdCrCtD
Cisplatin—CYP2B6—Doxorubicin—uterine cancer	0.000627	0.00229	CbGbCtD
Cisplatin—GSTM1—artery—uterine cancer	0.000623	0.0238	CbGeAlD
Cisplatin—GSTP1—oviduct—uterine cancer	0.000589	0.0225	CbGeAlD
Cisplatin—ABCB1—Etoposide—uterine cancer	0.000471	0.00172	CbGbCtD
Cisplatin—SLC31A2—myometrium—uterine cancer	0.00041	0.0157	CbGeAlD
Cisplatin—MPO—artery—uterine cancer	0.000401	0.0153	CbGeAlD
Cisplatin—MT1A—renal system—uterine cancer	0.000365	0.0139	CbGeAlD
Cisplatin—ATP7A—myometrium—uterine cancer	0.000361	0.0138	CbGeAlD
Cisplatin—GSTP1—exocrine gland—uterine cancer	0.00034	0.013	CbGeAlD
Cisplatin—CYP4A11—renal system—uterine cancer	0.000336	0.0128	CbGeAlD
Cisplatin—ABCB1—Doxorubicin—uterine cancer	0.000321	0.00117	CbGbCtD
Cisplatin—SLC31A2—uterine cervix—uterine cancer	0.000319	0.0122	CbGeAlD
Cisplatin—SOD1—myometrium—uterine cancer	0.000316	0.0121	CbGeAlD
Cisplatin—ATP7B—endometrium—uterine cancer	0.000316	0.0121	CbGeAlD
Cisplatin—SLC31A1—myometrium—uterine cancer	0.000308	0.0118	CbGeAlD
Cisplatin—SLC31A2—decidua—uterine cancer	0.000304	0.0116	CbGeAlD
Cisplatin—MT2A—renal system—uterine cancer	0.000304	0.0116	CbGeAlD
Cisplatin—GSTT1—renal system—uterine cancer	0.000297	0.0114	CbGeAlD
Cisplatin—MT1A—female reproductive system—uterine cancer	0.000292	0.0112	CbGeAlD
Cisplatin—ATP7B—uterus—uterine cancer	0.000291	0.0111	CbGeAlD
Cisplatin—SLC31A2—endometrium—uterine cancer	0.000289	0.011	CbGeAlD
Cisplatin—ATP7A—epithelium—uterine cancer	0.000284	0.0108	CbGeAlD
Cisplatin—ATP7A—uterine cervix—uterine cancer	0.000281	0.0107	CbGeAlD
Cisplatin—SLC31A2—mammalian vulva—uterine cancer	0.000279	0.0107	CbGeAlD
Cisplatin—ATP7A—decidua—uterine cancer	0.000268	0.0102	CbGeAlD
Cisplatin—ATP7A—renal system—uterine cancer	0.000263	0.01	CbGeAlD
Cisplatin—ATP7B—female reproductive system—uterine cancer	0.000262	0.00999	CbGeAlD
Cisplatin—ATP7A—endometrium—uterine cancer	0.000254	0.00971	CbGeAlD
Cisplatin—SOD1—uterine cervix—uterine cancer	0.000246	0.0094	CbGeAlD
Cisplatin—ATP7A—mammalian vulva—uterine cancer	0.000246	0.00939	CbGeAlD
Cisplatin—CYP4A11—vagina—uterine cancer	0.000243	0.00929	CbGeAlD
Cisplatin—MT2A—female reproductive system—uterine cancer	0.000243	0.00929	CbGeAlD
Cisplatin—ABCC6—renal system—uterine cancer	0.000241	0.00922	CbGeAlD
Cisplatin—SLC31A1—uterine cervix—uterine cancer	0.00024	0.00916	CbGeAlD
Cisplatin—SOD1—smooth muscle tissue—uterine cancer	0.000239	0.00913	CbGeAlD
Cisplatin—SLC31A2—female reproductive system—uterine cancer	0.000239	0.00913	CbGeAlD
Cisplatin—ATP7B—female gonad—uterine cancer	0.000238	0.00909	CbGeAlD
Cisplatin—GSTT1—female reproductive system—uterine cancer	0.000238	0.00909	CbGeAlD
Cisplatin—XDH—uterine cervix—uterine cancer	0.000237	0.00905	CbGeAlD
Cisplatin—ATP7B—vagina—uterine cancer	0.000237	0.00904	CbGeAlD
Cisplatin—SOD1—decidua—uterine cancer	0.000235	0.00895	CbGeAlD
Cisplatin—SLC31A1—renal system—uterine cancer	0.000224	0.00857	CbGeAlD
Cisplatin—SOD1—endometrium—uterine cancer	0.000223	0.0085	CbGeAlD
Cisplatin—XDH—renal system—uterine cancer	0.000222	0.00846	CbGeAlD
Cisplatin—MT2A—female gonad—uterine cancer	0.000221	0.00845	CbGeAlD
Cisplatin—GSTM1—renal system—uterine cancer	0.000219	0.00836	CbGeAlD
Cisplatin—SLC31A2—female gonad—uterine cancer	0.000218	0.00831	CbGeAlD
Cisplatin—SLC31A1—endometrium—uterine cancer	0.000217	0.00828	CbGeAlD
Cisplatin—SLC31A2—vagina—uterine cancer	0.000216	0.00826	CbGeAlD
Cisplatin—SOD1—mammalian vulva—uterine cancer	0.000215	0.00822	CbGeAlD
Cisplatin—XDH—endometrium—uterine cancer	0.000214	0.00818	CbGeAlD
Cisplatin—NQO1—myometrium—uterine cancer	0.000211	0.00805	CbGeAlD
Cisplatin—SLC31A1—mammalian vulva—uterine cancer	0.00021	0.00801	CbGeAlD
Cisplatin—XDH—mammalian vulva—uterine cancer	0.000207	0.00792	CbGeAlD
Cisplatin—SOD1—uterus—uterine cancer	0.000205	0.00783	CbGeAlD
Cisplatin—ATP7A—female gonad—uterine cancer	0.000192	0.00732	CbGeAlD
Cisplatin—ATP7A—vagina—uterine cancer	0.000191	0.00728	CbGeAlD
Cisplatin—GSTP1—myometrium—uterine cancer	0.000189	0.0072	CbGeAlD
Cisplatin—PTGS2—artery—uterine cancer	0.000182	0.00695	CbGeAlD
Cisplatin—SLC31A1—female reproductive system—uterine cancer	0.00018	0.00686	CbGeAlD
Cisplatin—XDH—female reproductive system—uterine cancer	0.000178	0.00678	CbGeAlD
Cisplatin—GSTM1—female reproductive system—uterine cancer	0.000175	0.0067	CbGeAlD
Cisplatin—ABCC5—uterine cervix—uterine cancer	0.000175	0.0067	CbGeAlD
Cisplatin—SLC22A2—renal system—uterine cancer	0.000174	0.00663	CbGeAlD
Cisplatin—MT1A—lymph node—uterine cancer	0.000171	0.00652	CbGeAlD
Cisplatin—SOD1—female gonad—uterine cancer	0.000168	0.00641	CbGeAlD
Cisplatin—ABCC5—decidua—uterine cancer	0.000167	0.00638	CbGeAlD
Cisplatin—SOD1—vagina—uterine cancer	0.000167	0.00637	CbGeAlD
Cisplatin—NQO1—epithelium—uterine cancer	0.000166	0.00632	CbGeAlD
Cisplatin—NQO1—uterine cervix—uterine cancer	0.000164	0.00627	CbGeAlD
Cisplatin—SLC31A1—female gonad—uterine cancer	0.000164	0.00624	CbGeAlD
Cisplatin—SLC31A1—vagina—uterine cancer	0.000163	0.00621	CbGeAlD
Cisplatin—XDH—vagina—uterine cancer	0.000161	0.00613	CbGeAlD
Cisplatin—GSTM1—female gonad—uterine cancer	0.00016	0.00609	CbGeAlD
Cisplatin—NQO1—smooth muscle tissue—uterine cancer	0.00016	0.00609	CbGeAlD
Cisplatin—NQO1—decidua—uterine cancer	0.000156	0.00597	CbGeAlD
Cisplatin—NQO1—renal system—uterine cancer	0.000154	0.00586	CbGeAlD
Cisplatin—ATP7B—lymph node—uterine cancer	0.000153	0.00585	CbGeAlD
Cisplatin—MPO—epithelium—uterine cancer	0.000152	0.00581	CbGeAlD
Cisplatin—NQO1—endometrium—uterine cancer	0.000148	0.00567	CbGeAlD
Cisplatin—GSTP1—epithelium—uterine cancer	0.000148	0.00565	CbGeAlD
Cisplatin—GSTP1—uterine cervix—uterine cancer	0.000147	0.0056	CbGeAlD
Cisplatin—NQO1—mammalian vulva—uterine cancer	0.000144	0.00548	CbGeAlD
Cisplatin—GSTP1—smooth muscle tissue—uterine cancer	0.000143	0.00544	CbGeAlD
Cisplatin—MPO—renal system—uterine cancer	0.000141	0.00539	CbGeAlD
Cisplatin—ABCC3—decidua—uterine cancer	0.00014	0.00536	CbGeAlD
Cisplatin—SLC31A2—lymph node—uterine cancer	0.00014	0.00534	CbGeAlD
Cisplatin—GSTP1—decidua—uterine cancer	0.00014	0.00533	CbGeAlD
Cisplatin—ABCC3—renal system—uterine cancer	0.000138	0.00526	CbGeAlD
Cisplatin—GSTP1—renal system—uterine cancer	0.000137	0.00524	CbGeAlD
Cisplatin—NQO1—uterus—uterine cancer	0.000137	0.00522	CbGeAlD
Cisplatin—GSTP1—endometrium—uterine cancer	0.000133	0.00506	CbGeAlD
Cisplatin—GSTP1—mammalian vulva—uterine cancer	0.000128	0.0049	CbGeAlD
Cisplatin—ATP7A—lymph node—uterine cancer	0.000123	0.00471	CbGeAlD
Cisplatin—NQO1—female reproductive system—uterine cancer	0.000123	0.00469	CbGeAlD
Cisplatin—GSTP1—uterus—uterine cancer	0.000122	0.00467	CbGeAlD
Cisplatin—ABCC5—female gonad—uterine cancer	0.00012	0.00457	CbGeAlD
Cisplatin—ABCC5—vagina—uterine cancer	0.000119	0.00454	CbGeAlD
Cisplatin—BCHE—myometrium—uterine cancer	0.000114	0.00436	CbGeAlD
Cisplatin—NQO1—female gonad—uterine cancer	0.000112	0.00427	CbGeAlD
Cisplatin—NQO1—vagina—uterine cancer	0.000111	0.00425	CbGeAlD
Cisplatin—ABCC3—female reproductive system—uterine cancer	0.00011	0.00421	CbGeAlD
Cisplatin—ABCG2—myometrium—uterine cancer	0.00011	0.00421	CbGeAlD
Cisplatin—ABCC2—renal system—uterine cancer	0.00011	0.0042	CbGeAlD
Cisplatin—GSTP1—female reproductive system—uterine cancer	0.00011	0.0042	CbGeAlD
Cisplatin—SOD1—lymph node—uterine cancer	0.000108	0.00412	CbGeAlD
Cisplatin—SLC31A1—lymph node—uterine cancer	0.000105	0.00401	CbGeAlD
Cisplatin—GSTM1—lymph node—uterine cancer	0.000103	0.00392	CbGeAlD
Cisplatin—ABCC3—female gonad—uterine cancer	0.0001	0.00383	CbGeAlD
Cisplatin—GSTP1—female gonad—uterine cancer	0.0001	0.00382	CbGeAlD
Cisplatin—GSTP1—vagina—uterine cancer	9.94e-05	0.00379	CbGeAlD
Cisplatin—BCHE—uterine cervix—uterine cancer	8.88e-05	0.00339	CbGeAlD
Cisplatin—ABCC2—female reproductive system—uterine cancer	8.82e-05	0.00337	CbGeAlD
Cisplatin—PTGS2—myometrium—uterine cancer	8.79e-05	0.00336	CbGeAlD
Cisplatin—BCHE—smooth muscle tissue—uterine cancer	8.63e-05	0.00329	CbGeAlD
Cisplatin—ABCG2—uterine cervix—uterine cancer	8.58e-05	0.00328	CbGeAlD
Cisplatin—ABCG2—decidua—uterine cancer	8.18e-05	0.00312	CbGeAlD
Cisplatin—BCHE—endometrium—uterine cancer	8.03e-05	0.00307	CbGeAlD
Cisplatin—BCHE—mammalian vulva—uterine cancer	7.77e-05	0.00297	CbGeAlD
Cisplatin—ABCG2—endometrium—uterine cancer	7.76e-05	0.00296	CbGeAlD
Cisplatin—ABCC5—lymph node—uterine cancer	7.69e-05	0.00294	CbGeAlD
Cisplatin—ABCG2—mammalian vulva—uterine cancer	7.51e-05	0.00287	CbGeAlD
Cisplatin—CYP2B6—renal system—uterine cancer	7.41e-05	0.00283	CbGeAlD
Cisplatin—BCHE—uterus—uterine cancer	7.4e-05	0.00283	CbGeAlD
Cisplatin—NQO1—lymph node—uterine cancer	7.19e-05	0.00275	CbGeAlD
Cisplatin—ABCG2—uterus—uterine cancer	7.15e-05	0.00273	CbGeAlD
Cisplatin—PTGS2—epithelium—uterine cancer	6.9e-05	0.00263	CbGeAlD
Cisplatin—PTGS2—uterine cervix—uterine cancer	6.84e-05	0.00261	CbGeAlD
Cisplatin—BCHE—female reproductive system—uterine cancer	6.65e-05	0.00254	CbGeAlD
Cisplatin—PTGS2—smooth muscle tissue—uterine cancer	6.65e-05	0.00254	CbGeAlD
Cisplatin—MPO—lymph node—uterine cancer	6.61e-05	0.00252	CbGeAlD
Cisplatin—ABCC3—lymph node—uterine cancer	6.46e-05	0.00246	CbGeAlD
Cisplatin—GSTP1—lymph node—uterine cancer	6.43e-05	0.00245	CbGeAlD
Cisplatin—PTGS2—renal system—uterine cancer	6.4e-05	0.00244	CbGeAlD
Cisplatin—PTGS2—endometrium—uterine cancer	6.19e-05	0.00236	CbGeAlD
Cisplatin—BCHE—vagina—uterine cancer	6.02e-05	0.0023	CbGeAlD
Cisplatin—CYP2B6—female reproductive system—uterine cancer	5.93e-05	0.00226	CbGeAlD
Cisplatin—CYP2C9—female reproductive system—uterine cancer	5.88e-05	0.00224	CbGeAlD
Cisplatin—ABCG2—female gonad—uterine cancer	5.85e-05	0.00223	CbGeAlD
Cisplatin—ABCG2—vagina—uterine cancer	5.82e-05	0.00222	CbGeAlD
Cisplatin—PTGS2—uterus—uterine cancer	5.7e-05	0.00218	CbGeAlD
Cisplatin—ABCB1—myometrium—uterine cancer	5.44e-05	0.00208	CbGeAlD
Cisplatin—CYP2B6—vagina—uterine cancer	5.37e-05	0.00205	CbGeAlD
Cisplatin—Paraesthesia—Medroxyprogesterone Acetate—uterine cancer	5.33e-05	0.00125	CcSEcCtD
Cisplatin—Dyspnoea—Medroxyprogesterone Acetate—uterine cancer	5.29e-05	0.00124	CcSEcCtD
Cisplatin—Hiccups—Epirubicin—uterine cancer	5.26e-05	0.00123	CcSEcCtD
Cisplatin—Hepatocellular injury—Epirubicin—uterine cancer	5.26e-05	0.00123	CcSEcCtD
Cisplatin—Ill-defined disorder—Dactinomycin—uterine cancer	5.26e-05	0.00123	CcSEcCtD
Cisplatin—Hyperuricaemia—Doxorubicin—uterine cancer	5.25e-05	0.00123	CcSEcCtD
Cisplatin—Anaemia—Dactinomycin—uterine cancer	5.24e-05	0.00123	CcSEcCtD
Cisplatin—Acute coronary syndrome—Etoposide—uterine cancer	5.18e-05	0.00121	CcSEcCtD
Cisplatin—Body temperature increased—Progesterone—uterine cancer	5.17e-05	0.00121	CcSEcCtD
Cisplatin—Hyperkalaemia—Epirubicin—uterine cancer	5.17e-05	0.00121	CcSEcCtD
Cisplatin—Renal failure—Etoposide—uterine cancer	5.16e-05	0.00121	CcSEcCtD
Cisplatin—ABCC2—lymph node—uterine cancer	5.16e-05	0.00197	CbGeAlD
Cisplatin—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	5.16e-05	0.00121	CcSEcCtD
Cisplatin—Ulcer—Doxorubicin—uterine cancer	5.15e-05	0.0012	CcSEcCtD
Cisplatin—Dysarthria—Doxorubicin—uterine cancer	5.15e-05	0.0012	CcSEcCtD
Cisplatin—Neuropathy peripheral—Etoposide—uterine cancer	5.15e-05	0.0012	CcSEcCtD
Cisplatin—Myocardial infarction—Etoposide—uterine cancer	5.15e-05	0.0012	CcSEcCtD
Cisplatin—PTGS2—female reproductive system—uterine cancer	5.13e-05	0.00196	CbGeAlD
Cisplatin—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	5.12e-05	0.0012	CcSEcCtD
Cisplatin—Stomatitis—Etoposide—uterine cancer	5.12e-05	0.0012	CcSEcCtD
Cisplatin—Malaise—Dactinomycin—uterine cancer	5.11e-05	0.0012	CcSEcCtD
Cisplatin—Leukopenia—Dactinomycin—uterine cancer	5.07e-05	0.00119	CcSEcCtD
Cisplatin—Skin exfoliation—Epirubicin—uterine cancer	5.02e-05	0.00118	CcSEcCtD
Cisplatin—Fluid retention—Epirubicin—uterine cancer	4.99e-05	0.00117	CcSEcCtD
Cisplatin—Hepatobiliary disease—Etoposide—uterine cancer	4.97e-05	0.00116	CcSEcCtD
Cisplatin—Blood uric acid increased—Doxorubicin—uterine cancer	4.96e-05	0.00116	CcSEcCtD
Cisplatin—Neuropathy—Epirubicin—uterine cancer	4.94e-05	0.00116	CcSEcCtD
Cisplatin—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	4.89e-05	0.00114	CcSEcCtD
Cisplatin—Hiccups—Doxorubicin—uterine cancer	4.87e-05	0.00114	CcSEcCtD
Cisplatin—Hepatocellular injury—Doxorubicin—uterine cancer	4.87e-05	0.00114	CcSEcCtD
Cisplatin—Myalgia—Dactinomycin—uterine cancer	4.83e-05	0.00113	CcSEcCtD
Cisplatin—Hypersensitivity—Progesterone—uterine cancer	4.82e-05	0.00113	CcSEcCtD
Cisplatin—Hyperkalaemia—Doxorubicin—uterine cancer	4.78e-05	0.00112	CcSEcCtD
Cisplatin—Discomfort—Dactinomycin—uterine cancer	4.77e-05	0.00112	CcSEcCtD
Cisplatin—Asthenia—Progesterone—uterine cancer	4.7e-05	0.0011	CcSEcCtD
Cisplatin—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	4.69e-05	0.0011	CcSEcCtD
Cisplatin—PTGS2—female gonad—uterine cancer	4.67e-05	0.00178	CbGeAlD
Cisplatin—Urinary tract disorder—Etoposide—uterine cancer	4.65e-05	0.00109	CcSEcCtD
Cisplatin—Skin exfoliation—Doxorubicin—uterine cancer	4.65e-05	0.00109	CcSEcCtD
Cisplatin—PTGS2—vagina—uterine cancer	4.64e-05	0.00177	CbGeAlD
Cisplatin—Oedema—Dactinomycin—uterine cancer	4.63e-05	0.00108	CcSEcCtD
Cisplatin—Fluid retention—Doxorubicin—uterine cancer	4.62e-05	0.00108	CcSEcCtD
Cisplatin—Urethral disorder—Etoposide—uterine cancer	4.62e-05	0.00108	CcSEcCtD
Cisplatin—Infection—Dactinomycin—uterine cancer	4.6e-05	0.00108	CcSEcCtD
Cisplatin—Neuropathy—Doxorubicin—uterine cancer	4.57e-05	0.00107	CcSEcCtD
Cisplatin—Thrombocytopenia—Dactinomycin—uterine cancer	4.53e-05	0.00106	CcSEcCtD
Cisplatin—Diarrhoea—Progesterone—uterine cancer	4.48e-05	0.00105	CcSEcCtD
Cisplatin—Phlebitis—Epirubicin—uterine cancer	4.43e-05	0.00104	CcSEcCtD
Cisplatin—Anorexia—Dactinomycin—uterine cancer	4.41e-05	0.00103	CcSEcCtD
Cisplatin—Eye disorder—Etoposide—uterine cancer	4.4e-05	0.00103	CcSEcCtD
Cisplatin—Flushing—Etoposide—uterine cancer	4.37e-05	0.00102	CcSEcCtD
Cisplatin—Cardiac disorder—Etoposide—uterine cancer	4.37e-05	0.00102	CcSEcCtD
Cisplatin—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	4.37e-05	0.00102	CcSEcCtD
Cisplatin—ABCB1—epithelium—uterine cancer	4.27e-05	0.00163	CbGeAlD
Cisplatin—Immune system disorder—Etoposide—uterine cancer	4.26e-05	0.000996	CcSEcCtD
Cisplatin—Asthenia—Medroxyprogesterone Acetate—uterine cancer	4.26e-05	0.000996	CcSEcCtD
Cisplatin—Mediastinal disorder—Etoposide—uterine cancer	4.25e-05	0.000994	CcSEcCtD
Cisplatin—ABCB1—uterine cervix—uterine cancer	4.23e-05	0.00162	CbGeAlD
Cisplatin—Musculoskeletal discomfort—Dactinomycin—uterine cancer	4.22e-05	0.000986	CcSEcCtD
Cisplatin—Cardiac failure congestive—Epirubicin—uterine cancer	4.21e-05	0.000985	CcSEcCtD
Cisplatin—Alopecia—Etoposide—uterine cancer	4.16e-05	0.000974	CcSEcCtD
Cisplatin—Vomiting—Progesterone—uterine cancer	4.16e-05	0.000974	CcSEcCtD
Cisplatin—Renal failure acute—Epirubicin—uterine cancer	4.14e-05	0.000968	CcSEcCtD
Cisplatin—Rash—Progesterone—uterine cancer	4.13e-05	0.000966	CcSEcCtD
Cisplatin—Dermatitis—Progesterone—uterine cancer	4.12e-05	0.000965	CcSEcCtD
Cisplatin—Phlebitis—Doxorubicin—uterine cancer	4.1e-05	0.00096	CcSEcCtD
Cisplatin—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	4.06e-05	0.000949	CcSEcCtD
Cisplatin—ABCB1—decidua—uterine cancer	4.03e-05	0.00154	CbGeAlD
Cisplatin—Decreased appetite—Dactinomycin—uterine cancer	4.02e-05	0.000941	CcSEcCtD
Cisplatin—ABCB1—renal system—uterine cancer	3.96e-05	0.00151	CbGeAlD
Cisplatin—Pain—Dactinomycin—uterine cancer	3.96e-05	0.000926	CcSEcCtD
Cisplatin—Anaphylactoid reaction—Epirubicin—uterine cancer	3.95e-05	0.000923	CcSEcCtD
Cisplatin—Muscle spasms—Etoposide—uterine cancer	3.94e-05	0.000923	CcSEcCtD
Cisplatin—Cerebrovascular accident—Epirubicin—uterine cancer	3.9e-05	0.000912	CcSEcCtD
Cisplatin—Cardiac failure congestive—Doxorubicin—uterine cancer	3.9e-05	0.000912	CcSEcCtD
Cisplatin—BCHE—lymph node—uterine cancer	3.89e-05	0.00149	CbGeAlD
Cisplatin—Nausea—Progesterone—uterine cancer	3.89e-05	0.00091	CcSEcCtD
Cisplatin—Hyponatraemia—Epirubicin—uterine cancer	3.83e-05	0.000897	CcSEcCtD
Cisplatin—ABCB1—endometrium—uterine cancer	3.83e-05	0.00146	CbGeAlD
Cisplatin—Renal failure acute—Doxorubicin—uterine cancer	3.83e-05	0.000895	CcSEcCtD
Cisplatin—Gastrointestinal haemorrhage—Epirubicin—uterine cancer	3.82e-05	0.000893	CcSEcCtD
Cisplatin—Feeling abnormal—Dactinomycin—uterine cancer	3.81e-05	0.000892	CcSEcCtD
Cisplatin—Ill-defined disorder—Etoposide—uterine cancer	3.81e-05	0.000891	CcSEcCtD
Cisplatin—Anaemia—Etoposide—uterine cancer	3.79e-05	0.000887	CcSEcCtD
Cisplatin—Vomiting—Medroxyprogesterone Acetate—uterine cancer	3.77e-05	0.000882	CcSEcCtD
Cisplatin—ABCG2—lymph node—uterine cancer	3.76e-05	0.00144	CbGeAlD
Cisplatin—Rash—Medroxyprogesterone Acetate—uterine cancer	3.74e-05	0.000875	CcSEcCtD
Cisplatin—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	3.74e-05	0.000874	CcSEcCtD
Cisplatin—ABCB1—mammalian vulva—uterine cancer	3.7e-05	0.00141	CbGeAlD
Cisplatin—Malaise—Etoposide—uterine cancer	3.7e-05	0.000866	CcSEcCtD
Cisplatin—Face oedema—Epirubicin—uterine cancer	3.69e-05	0.000862	CcSEcCtD
Cisplatin—Leukopenia—Etoposide—uterine cancer	3.67e-05	0.000859	CcSEcCtD
Cisplatin—Body temperature increased—Dactinomycin—uterine cancer	3.66e-05	0.000856	CcSEcCtD
Cisplatin—Anaphylactoid reaction—Doxorubicin—uterine cancer	3.65e-05	0.000854	CcSEcCtD
Cisplatin—Cerebrovascular accident—Doxorubicin—uterine cancer	3.61e-05	0.000844	CcSEcCtD
Cisplatin—Blood creatinine increased—Epirubicin—uterine cancer	3.58e-05	0.000837	CcSEcCtD
Cisplatin—Convulsion—Etoposide—uterine cancer	3.55e-05	0.000832	CcSEcCtD
Cisplatin—Dehydration—Epirubicin—uterine cancer	3.55e-05	0.000831	CcSEcCtD
Cisplatin—Hyponatraemia—Doxorubicin—uterine cancer	3.55e-05	0.00083	CcSEcCtD
Cisplatin—Gastrointestinal haemorrhage—Doxorubicin—uterine cancer	3.53e-05	0.000827	CcSEcCtD
Cisplatin—ABCB1—uterus—uterine cancer	3.53e-05	0.00135	CbGeAlD
Cisplatin—Nausea—Medroxyprogesterone Acetate—uterine cancer	3.52e-05	0.000824	CcSEcCtD
Cisplatin—Orthostatic hypotension—Epirubicin—uterine cancer	3.49e-05	0.000816	CcSEcCtD
Cisplatin—Hypokalaemia—Epirubicin—uterine cancer	3.48e-05	0.000813	CcSEcCtD
Cisplatin—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	3.47e-05	0.000812	CcSEcCtD
Cisplatin—Discomfort—Etoposide—uterine cancer	3.45e-05	0.000807	CcSEcCtD
Cisplatin—Breast disorder—Epirubicin—uterine cancer	3.45e-05	0.000807	CcSEcCtD
Cisplatin—Aspartate aminotransferase increased—Epirubicin—uterine cancer	3.44e-05	0.000804	CcSEcCtD
Cisplatin—Nasopharyngitis—Epirubicin—uterine cancer	3.41e-05	0.000799	CcSEcCtD
Cisplatin—Face oedema—Doxorubicin—uterine cancer	3.41e-05	0.000798	CcSEcCtD
Cisplatin—Hypersensitivity—Dactinomycin—uterine cancer	3.41e-05	0.000797	CcSEcCtD
Cisplatin—Anaphylactic shock—Etoposide—uterine cancer	3.35e-05	0.000783	CcSEcCtD
Cisplatin—Infection—Etoposide—uterine cancer	3.33e-05	0.000778	CcSEcCtD
Cisplatin—Asthenia—Dactinomycin—uterine cancer	3.32e-05	0.000777	CcSEcCtD
Cisplatin—Blood creatinine increased—Doxorubicin—uterine cancer	3.31e-05	0.000774	CcSEcCtD
Cisplatin—Dehydration—Doxorubicin—uterine cancer	3.29e-05	0.000769	CcSEcCtD
Cisplatin—Thrombocytopenia—Etoposide—uterine cancer	3.28e-05	0.000767	CcSEcCtD
Cisplatin—Tachycardia—Etoposide—uterine cancer	3.27e-05	0.000765	CcSEcCtD
Cisplatin—Skin disorder—Etoposide—uterine cancer	3.25e-05	0.000761	CcSEcCtD
Cisplatin—Hyperhidrosis—Etoposide—uterine cancer	3.24e-05	0.000757	CcSEcCtD
Cisplatin—Pancreatitis—Epirubicin—uterine cancer	3.24e-05	0.000757	CcSEcCtD
Cisplatin—Orthostatic hypotension—Doxorubicin—uterine cancer	3.23e-05	0.000755	CcSEcCtD
Cisplatin—Hypokalaemia—Doxorubicin—uterine cancer	3.22e-05	0.000752	CcSEcCtD
Cisplatin—Breast disorder—Doxorubicin—uterine cancer	3.19e-05	0.000747	CcSEcCtD
Cisplatin—Anorexia—Etoposide—uterine cancer	3.19e-05	0.000747	CcSEcCtD
Cisplatin—Aspartate aminotransferase increased—Doxorubicin—uterine cancer	3.18e-05	0.000744	CcSEcCtD
Cisplatin—ABCB1—female reproductive system—uterine cancer	3.17e-05	0.00121	CbGeAlD
Cisplatin—Diarrhoea—Dactinomycin—uterine cancer	3.17e-05	0.000741	CcSEcCtD
Cisplatin—Nasopharyngitis—Doxorubicin—uterine cancer	3.16e-05	0.000739	CcSEcCtD
Cisplatin—Pancytopenia—Epirubicin—uterine cancer	3.13e-05	0.000733	CcSEcCtD
Cisplatin—Hypotension—Etoposide—uterine cancer	3.13e-05	0.000732	CcSEcCtD
Cisplatin—Paraesthesia—Etoposide—uterine cancer	3.01e-05	0.000703	CcSEcCtD
Cisplatin—PTGS2—lymph node—uterine cancer	3e-05	0.00114	CbGeAlD
Cisplatin—Pancreatitis—Doxorubicin—uterine cancer	2.99e-05	0.0007	CcSEcCtD
Cisplatin—Dyspnoea—Etoposide—uterine cancer	2.99e-05	0.000698	CcSEcCtD
Cisplatin—Vomiting—Dactinomycin—uterine cancer	2.94e-05	0.000688	CcSEcCtD
Cisplatin—Rash—Dactinomycin—uterine cancer	2.92e-05	0.000682	CcSEcCtD
Cisplatin—Decreased appetite—Etoposide—uterine cancer	2.91e-05	0.000681	CcSEcCtD
Cisplatin—Pancytopenia—Doxorubicin—uterine cancer	2.9e-05	0.000679	CcSEcCtD
Cisplatin—Renal failure—Epirubicin—uterine cancer	2.89e-05	0.000677	CcSEcCtD
Cisplatin—Gastrointestinal disorder—Etoposide—uterine cancer	2.89e-05	0.000676	CcSEcCtD
Cisplatin—ABCB1—female gonad—uterine cancer	2.89e-05	0.0011	CbGeAlD
Cisplatin—Neuropathy peripheral—Epirubicin—uterine cancer	2.88e-05	0.000675	CcSEcCtD
Cisplatin—Stomatitis—Epirubicin—uterine cancer	2.87e-05	0.000671	CcSEcCtD
Cisplatin—ABCB1—vagina—uterine cancer	2.87e-05	0.00109	CbGeAlD
Cisplatin—Pain—Etoposide—uterine cancer	2.86e-05	0.00067	CcSEcCtD
Cisplatin—Conjunctivitis—Epirubicin—uterine cancer	2.86e-05	0.000669	CcSEcCtD
Cisplatin—Hepatobiliary disease—Epirubicin—uterine cancer	2.78e-05	0.000651	CcSEcCtD
Cisplatin—Feeling abnormal—Etoposide—uterine cancer	2.76e-05	0.000646	CcSEcCtD
Cisplatin—Nausea—Dactinomycin—uterine cancer	2.75e-05	0.000643	CcSEcCtD
Cisplatin—Bradycardia—Epirubicin—uterine cancer	2.69e-05	0.000629	CcSEcCtD
Cisplatin—Renal failure—Doxorubicin—uterine cancer	2.68e-05	0.000626	CcSEcCtD
Cisplatin—Neuropathy peripheral—Doxorubicin—uterine cancer	2.67e-05	0.000624	CcSEcCtD
Cisplatin—Stomatitis—Doxorubicin—uterine cancer	2.65e-05	0.000621	CcSEcCtD
Cisplatin—Body temperature increased—Etoposide—uterine cancer	2.65e-05	0.000619	CcSEcCtD
Cisplatin—Conjunctivitis—Doxorubicin—uterine cancer	2.65e-05	0.000619	CcSEcCtD
Cisplatin—Urinary tract disorder—Epirubicin—uterine cancer	2.61e-05	0.00061	CcSEcCtD
Cisplatin—Connective tissue disorder—Epirubicin—uterine cancer	2.6e-05	0.000607	CcSEcCtD
Cisplatin—Urethral disorder—Epirubicin—uterine cancer	2.59e-05	0.000606	CcSEcCtD
Cisplatin—Hepatobiliary disease—Doxorubicin—uterine cancer	2.58e-05	0.000602	CcSEcCtD
Cisplatin—Visual impairment—Epirubicin—uterine cancer	2.55e-05	0.000596	CcSEcCtD
Cisplatin—Bradycardia—Doxorubicin—uterine cancer	2.49e-05	0.000582	CcSEcCtD
Cisplatin—Eye disorder—Epirubicin—uterine cancer	2.47e-05	0.000578	CcSEcCtD
Cisplatin—Hypersensitivity—Etoposide—uterine cancer	2.47e-05	0.000577	CcSEcCtD
Cisplatin—Tinnitus—Epirubicin—uterine cancer	2.46e-05	0.000576	CcSEcCtD
Cisplatin—Cardiac disorder—Epirubicin—uterine cancer	2.45e-05	0.000574	CcSEcCtD
Cisplatin—Flushing—Epirubicin—uterine cancer	2.45e-05	0.000574	CcSEcCtD
Cisplatin—Urinary tract disorder—Doxorubicin—uterine cancer	2.41e-05	0.000565	CcSEcCtD
Cisplatin—Asthenia—Etoposide—uterine cancer	2.4e-05	0.000562	CcSEcCtD
Cisplatin—Connective tissue disorder—Doxorubicin—uterine cancer	2.4e-05	0.000562	CcSEcCtD
Cisplatin—Urethral disorder—Doxorubicin—uterine cancer	2.4e-05	0.000561	CcSEcCtD
Cisplatin—Immune system disorder—Epirubicin—uterine cancer	2.39e-05	0.000558	CcSEcCtD
Cisplatin—Mediastinal disorder—Epirubicin—uterine cancer	2.38e-05	0.000557	CcSEcCtD
Cisplatin—Arrhythmia—Epirubicin—uterine cancer	2.36e-05	0.000552	CcSEcCtD
Cisplatin—Visual impairment—Doxorubicin—uterine cancer	2.36e-05	0.000551	CcSEcCtD
Cisplatin—Alopecia—Epirubicin—uterine cancer	2.33e-05	0.000546	CcSEcCtD
Cisplatin—Erythema—Epirubicin—uterine cancer	2.3e-05	0.000538	CcSEcCtD
Cisplatin—Malnutrition—Epirubicin—uterine cancer	2.3e-05	0.000538	CcSEcCtD
Cisplatin—Diarrhoea—Etoposide—uterine cancer	2.29e-05	0.000536	CcSEcCtD
Cisplatin—Eye disorder—Doxorubicin—uterine cancer	2.28e-05	0.000534	CcSEcCtD
Cisplatin—Tinnitus—Doxorubicin—uterine cancer	2.28e-05	0.000533	CcSEcCtD
Cisplatin—Cardiac disorder—Doxorubicin—uterine cancer	2.27e-05	0.000531	CcSEcCtD
Cisplatin—Flushing—Doxorubicin—uterine cancer	2.27e-05	0.000531	CcSEcCtD
Cisplatin—Flatulence—Epirubicin—uterine cancer	2.27e-05	0.00053	CcSEcCtD
Cisplatin—Muscle spasms—Epirubicin—uterine cancer	2.21e-05	0.000517	CcSEcCtD
Cisplatin—Immune system disorder—Doxorubicin—uterine cancer	2.21e-05	0.000517	CcSEcCtD
Cisplatin—Mediastinal disorder—Doxorubicin—uterine cancer	2.2e-05	0.000515	CcSEcCtD
Cisplatin—Arrhythmia—Doxorubicin—uterine cancer	2.18e-05	0.000511	CcSEcCtD
Cisplatin—Vision blurred—Epirubicin—uterine cancer	2.17e-05	0.000507	CcSEcCtD
Cisplatin—Alopecia—Doxorubicin—uterine cancer	2.16e-05	0.000505	CcSEcCtD
Cisplatin—Ill-defined disorder—Epirubicin—uterine cancer	2.13e-05	0.000499	CcSEcCtD
Cisplatin—Vomiting—Etoposide—uterine cancer	2.13e-05	0.000498	CcSEcCtD
Cisplatin—Erythema—Doxorubicin—uterine cancer	2.13e-05	0.000498	CcSEcCtD
Cisplatin—Malnutrition—Doxorubicin—uterine cancer	2.13e-05	0.000498	CcSEcCtD
Cisplatin—Anaemia—Epirubicin—uterine cancer	2.13e-05	0.000497	CcSEcCtD
Cisplatin—Rash—Etoposide—uterine cancer	2.11e-05	0.000494	CcSEcCtD
Cisplatin—Dermatitis—Etoposide—uterine cancer	2.11e-05	0.000493	CcSEcCtD
Cisplatin—Flatulence—Doxorubicin—uterine cancer	2.1e-05	0.000491	CcSEcCtD
Cisplatin—Malaise—Epirubicin—uterine cancer	2.07e-05	0.000485	CcSEcCtD
Cisplatin—Leukopenia—Epirubicin—uterine cancer	2.06e-05	0.000482	CcSEcCtD
Cisplatin—Muscle spasms—Doxorubicin—uterine cancer	2.05e-05	0.000479	CcSEcCtD
Cisplatin—Vision blurred—Doxorubicin—uterine cancer	2.01e-05	0.000469	CcSEcCtD
Cisplatin—Convulsion—Epirubicin—uterine cancer	1.99e-05	0.000466	CcSEcCtD
Cisplatin—Nausea—Etoposide—uterine cancer	1.99e-05	0.000465	CcSEcCtD
Cisplatin—Ill-defined disorder—Doxorubicin—uterine cancer	1.97e-05	0.000462	CcSEcCtD
Cisplatin—Anaemia—Doxorubicin—uterine cancer	1.97e-05	0.00046	CcSEcCtD
Cisplatin—Myalgia—Epirubicin—uterine cancer	1.96e-05	0.000458	CcSEcCtD
Cisplatin—Anxiety—Epirubicin—uterine cancer	1.95e-05	0.000456	CcSEcCtD
Cisplatin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	1.94e-05	0.000455	CcSEcCtD
Cisplatin—Discomfort—Epirubicin—uterine cancer	1.93e-05	0.000453	CcSEcCtD
Cisplatin—Malaise—Doxorubicin—uterine cancer	1.92e-05	0.000449	CcSEcCtD
Cisplatin—Leukopenia—Doxorubicin—uterine cancer	1.9e-05	0.000446	CcSEcCtD
Cisplatin—Anaphylactic shock—Epirubicin—uterine cancer	1.88e-05	0.000439	CcSEcCtD
Cisplatin—Oedema—Epirubicin—uterine cancer	1.88e-05	0.000439	CcSEcCtD
Cisplatin—Infection—Epirubicin—uterine cancer	1.86e-05	0.000436	CcSEcCtD
Cisplatin—ABCB1—lymph node—uterine cancer	1.86e-05	0.000708	CbGeAlD
Cisplatin—Convulsion—Doxorubicin—uterine cancer	1.84e-05	0.000431	CcSEcCtD
Cisplatin—Nervous system disorder—Epirubicin—uterine cancer	1.84e-05	0.000431	CcSEcCtD
Cisplatin—Thrombocytopenia—Epirubicin—uterine cancer	1.84e-05	0.00043	CcSEcCtD
Cisplatin—Tachycardia—Epirubicin—uterine cancer	1.83e-05	0.000429	CcSEcCtD
Cisplatin—Skin disorder—Epirubicin—uterine cancer	1.82e-05	0.000427	CcSEcCtD
Cisplatin—Hyperhidrosis—Epirubicin—uterine cancer	1.81e-05	0.000424	CcSEcCtD
Cisplatin—Myalgia—Doxorubicin—uterine cancer	1.81e-05	0.000424	CcSEcCtD
Cisplatin—Anxiety—Doxorubicin—uterine cancer	1.81e-05	0.000422	CcSEcCtD
Cisplatin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	1.8e-05	0.000421	CcSEcCtD
Cisplatin—Discomfort—Doxorubicin—uterine cancer	1.79e-05	0.000419	CcSEcCtD
Cisplatin—Anorexia—Epirubicin—uterine cancer	1.79e-05	0.000419	CcSEcCtD
Cisplatin—Hypotension—Epirubicin—uterine cancer	1.75e-05	0.00041	CcSEcCtD
Cisplatin—Anaphylactic shock—Doxorubicin—uterine cancer	1.74e-05	0.000406	CcSEcCtD
Cisplatin—Oedema—Doxorubicin—uterine cancer	1.74e-05	0.000406	CcSEcCtD
Cisplatin—Infection—Doxorubicin—uterine cancer	1.73e-05	0.000404	CcSEcCtD
Cisplatin—Musculoskeletal discomfort—Epirubicin—uterine cancer	1.71e-05	0.0004	CcSEcCtD
Cisplatin—Nervous system disorder—Doxorubicin—uterine cancer	1.7e-05	0.000398	CcSEcCtD
Cisplatin—Thrombocytopenia—Doxorubicin—uterine cancer	1.7e-05	0.000398	CcSEcCtD
Cisplatin—Tachycardia—Doxorubicin—uterine cancer	1.7e-05	0.000397	CcSEcCtD
Cisplatin—Skin disorder—Doxorubicin—uterine cancer	1.69e-05	0.000395	CcSEcCtD
Cisplatin—Paraesthesia—Epirubicin—uterine cancer	1.69e-05	0.000394	CcSEcCtD
Cisplatin—Hyperhidrosis—Doxorubicin—uterine cancer	1.68e-05	0.000393	CcSEcCtD
Cisplatin—Dyspnoea—Epirubicin—uterine cancer	1.67e-05	0.000391	CcSEcCtD
Cisplatin—Anorexia—Doxorubicin—uterine cancer	1.66e-05	0.000387	CcSEcCtD
Cisplatin—Decreased appetite—Epirubicin—uterine cancer	1.63e-05	0.000382	CcSEcCtD
Cisplatin—Hypotension—Doxorubicin—uterine cancer	1.62e-05	0.00038	CcSEcCtD
Cisplatin—Gastrointestinal disorder—Epirubicin—uterine cancer	1.62e-05	0.000379	CcSEcCtD
Cisplatin—Pain—Epirubicin—uterine cancer	1.61e-05	0.000375	CcSEcCtD
Cisplatin—Musculoskeletal discomfort—Doxorubicin—uterine cancer	1.58e-05	0.00037	CcSEcCtD
Cisplatin—Paraesthesia—Doxorubicin—uterine cancer	1.56e-05	0.000365	CcSEcCtD
Cisplatin—Dyspnoea—Doxorubicin—uterine cancer	1.55e-05	0.000362	CcSEcCtD
Cisplatin—Feeling abnormal—Epirubicin—uterine cancer	1.55e-05	0.000362	CcSEcCtD
Cisplatin—Decreased appetite—Doxorubicin—uterine cancer	1.51e-05	0.000353	CcSEcCtD
Cisplatin—Gastrointestinal disorder—Doxorubicin—uterine cancer	1.5e-05	0.000351	CcSEcCtD
Cisplatin—Pain—Doxorubicin—uterine cancer	1.49e-05	0.000347	CcSEcCtD
Cisplatin—Body temperature increased—Epirubicin—uterine cancer	1.48e-05	0.000347	CcSEcCtD
Cisplatin—Feeling abnormal—Doxorubicin—uterine cancer	1.43e-05	0.000335	CcSEcCtD
Cisplatin—Hypersensitivity—Epirubicin—uterine cancer	1.38e-05	0.000324	CcSEcCtD
Cisplatin—Body temperature increased—Doxorubicin—uterine cancer	1.37e-05	0.000321	CcSEcCtD
Cisplatin—Asthenia—Epirubicin—uterine cancer	1.35e-05	0.000315	CcSEcCtD
Cisplatin—Diarrhoea—Epirubicin—uterine cancer	1.28e-05	0.0003	CcSEcCtD
Cisplatin—Hypersensitivity—Doxorubicin—uterine cancer	1.28e-05	0.000299	CcSEcCtD
Cisplatin—Asthenia—Doxorubicin—uterine cancer	1.25e-05	0.000292	CcSEcCtD
Cisplatin—Vomiting—Epirubicin—uterine cancer	1.19e-05	0.000279	CcSEcCtD
Cisplatin—Diarrhoea—Doxorubicin—uterine cancer	1.19e-05	0.000278	CcSEcCtD
Cisplatin—Rash—Epirubicin—uterine cancer	1.18e-05	0.000277	CcSEcCtD
Cisplatin—Dermatitis—Epirubicin—uterine cancer	1.18e-05	0.000277	CcSEcCtD
Cisplatin—Nausea—Epirubicin—uterine cancer	1.11e-05	0.000261	CcSEcCtD
Cisplatin—Vomiting—Doxorubicin—uterine cancer	1.1e-05	0.000258	CcSEcCtD
Cisplatin—Rash—Doxorubicin—uterine cancer	1.1e-05	0.000256	CcSEcCtD
Cisplatin—Dermatitis—Doxorubicin—uterine cancer	1.09e-05	0.000256	CcSEcCtD
Cisplatin—Nausea—Doxorubicin—uterine cancer	1.03e-05	0.000241	CcSEcCtD
Cisplatin—MT2A—Immune System—EP300—uterine cancer	6.23e-06	0.000281	CbGpPWpGaD
Cisplatin—PTGS2—C-MYB transcription factor network—HRAS—uterine cancer	6.21e-06	0.00028	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—RRM2—uterine cancer	6.2e-06	0.00028	CbGpPWpGaD
Cisplatin—SOD1—Hemostasis—KRAS—uterine cancer	6.13e-06	0.000277	CbGpPWpGaD
Cisplatin—ABCC5—Disease—CDKN2B—uterine cancer	6.06e-06	0.000274	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—DCN—uterine cancer	6.02e-06	0.000272	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—MTHFR—uterine cancer	5.97e-06	0.000269	CbGpPWpGaD
Cisplatin—XDH—Metabolism—CYP19A1—uterine cancer	5.9e-06	0.000267	CbGpPWpGaD
Cisplatin—XDH—Metabolism—STK11—uterine cancer	5.9e-06	0.000267	CbGpPWpGaD
Cisplatin—MT2A—Immune System—NRAS—uterine cancer	5.83e-06	0.000263	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	5.78e-06	0.000261	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—POLD1—uterine cancer	5.68e-06	0.000257	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—CYP11A1—uterine cancer	5.67e-06	0.000256	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—STK11—uterine cancer	5.66e-06	0.000256	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—CYP19A1—uterine cancer	5.66e-06	0.000256	CbGpPWpGaD
Cisplatin—SOD1—Hemostasis—PIK3CA—uterine cancer	5.63e-06	0.000254	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—uterine cancer	5.58e-06	0.000252	CbGpPWpGaD
Cisplatin—ABCC5—Disease—SMAD3—uterine cancer	5.53e-06	0.00025	CbGpPWpGaD
Cisplatin—SOD1—Hemostasis—TP53—uterine cancer	5.45e-06	0.000246	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	5.44e-06	0.000246	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	5.36e-06	0.000242	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—AKR1C3—uterine cancer	5.35e-06	0.000242	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—AKR1C1—uterine cancer	5.31e-06	0.00024	CbGpPWpGaD
Cisplatin—PTGS2—Disease—RNF43—uterine cancer	5.3e-06	0.000239	CbGpPWpGaD
Cisplatin—ABCC5—Disease—FGFR2—uterine cancer	5.27e-06	0.000238	CbGpPWpGaD
Cisplatin—SOD1—Hemostasis—HRAS—uterine cancer	5.21e-06	0.000235	CbGpPWpGaD
Cisplatin—GSTT1—Metabolism—PTEN—uterine cancer	5.15e-06	0.000233	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—POLD1—uterine cancer	5.13e-06	0.000232	CbGpPWpGaD
Cisplatin—ABCC5—Disease—MTHFR—uterine cancer	5.08e-06	0.000229	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—MTHFR—uterine cancer	5.07e-06	0.000229	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—POLD1—uterine cancer	5.07e-06	0.000229	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	5.06e-06	0.000228	CbGpPWpGaD
Cisplatin—MT2A—Immune System—KRAS—uterine cancer	5.02e-06	0.000227	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—AKR1B1—uterine cancer	4.98e-06	0.000225	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—STAR—uterine cancer	4.98e-06	0.000225	CbGpPWpGaD
Cisplatin—PTGS2—Spinal Cord Injury—TP53—uterine cancer	4.95e-06	0.000223	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—MTHFR—uterine cancer	4.94e-06	0.000223	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	4.93e-06	0.000223	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	4.93e-06	0.000222	CbGpPWpGaD
Cisplatin—GSTT1—Metabolism—EP300—uterine cancer	4.91e-06	0.000222	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—STK11—uterine cancer	4.91e-06	0.000222	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—CYP19A1—uterine cancer	4.91e-06	0.000222	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—SRD5A2—uterine cancer	4.89e-06	0.000221	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—NDUFB11—uterine cancer	4.89e-06	0.000221	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—AKR1C1—uterine cancer	4.8e-06	0.000217	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—AKR1B1—uterine cancer	4.79e-06	0.000216	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—STAR—uterine cancer	4.79e-06	0.000216	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—AKR1C1—uterine cancer	4.75e-06	0.000214	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—RRM2—uterine cancer	4.74e-06	0.000214	CbGpPWpGaD
Cisplatin—ABCB1—HIF-1-alpha transcription factor network—AKT1—uterine cancer	4.71e-06	0.000213	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	4.7e-06	0.000212	CbGpPWpGaD
Cisplatin—MT2A—Immune System—PIK3CA—uterine cancer	4.61e-06	0.000208	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	4.61e-06	0.000208	CbGpPWpGaD
Cisplatin—SOD1—Hemostasis—AKT1—uterine cancer	4.6e-06	0.000208	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—DCN—uterine cancer	4.6e-06	0.000208	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—SRD5A2—uterine cancer	4.56e-06	0.000206	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—NDUFB11—uterine cancer	4.56e-06	0.000206	CbGpPWpGaD
Cisplatin—BCHE—Transmission across Chemical Synapses—HRAS—uterine cancer	4.51e-06	0.000204	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	4.45e-06	0.000201	CbGpPWpGaD
Cisplatin—XDH—Metabolism—MTHFR—uterine cancer	4.44e-06	0.0002	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	4.43e-06	0.0002	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism of lipids and lipoproteins—EP300—uterine cancer	4.39e-06	0.000198	CbGpPWpGaD
Cisplatin—PTGS2—Disease—AKR1C1—uterine cancer	4.37e-06	0.000197	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—CYP11A1—uterine cancer	4.33e-06	0.000196	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—RRM2—uterine cancer	4.27e-06	0.000193	CbGpPWpGaD
Cisplatin—MT2A—Immune System—HRAS—uterine cancer	4.26e-06	0.000193	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—MTHFR—uterine cancer	4.25e-06	0.000192	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—RRM2—uterine cancer	4.23e-06	0.000191	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	4.19e-06	0.000189	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—STK11—uterine cancer	4.17e-06	0.000188	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—CYP19A1—uterine cancer	4.17e-06	0.000188	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—DCN—uterine cancer	4.15e-06	0.000187	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—DCN—uterine cancer	4.11e-06	0.000185	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	4.1e-06	0.000185	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—AKR1C3—uterine cancer	4.09e-06	0.000185	CbGpPWpGaD
Cisplatin—SLC22A2—Transmission across Chemical Synapses—HRAS—uterine cancer	4.03e-06	0.000182	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	3.92e-06	0.000177	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—POLD1—uterine cancer	3.91e-06	0.000177	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—CYP11A1—uterine cancer	3.91e-06	0.000177	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—CYP11A1—uterine cancer	3.87e-06	0.000175	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	3.8e-06	0.000171	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	3.79e-06	0.000171	CbGpPWpGaD
Cisplatin—PTGS2—Disease—DCN—uterine cancer	3.78e-06	0.000171	CbGpPWpGaD
Cisplatin—MT2A—Immune System—AKT1—uterine cancer	3.77e-06	0.00017	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—POLD1—uterine cancer	3.76e-06	0.00017	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism of lipids and lipoproteins—EP300—uterine cancer	3.73e-06	0.000169	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—AKR1C3—uterine cancer	3.69e-06	0.000167	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—MTHFR—uterine cancer	3.69e-06	0.000166	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—AKR1C1—uterine cancer	3.66e-06	0.000165	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—AKR1C3—uterine cancer	3.65e-06	0.000165	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of proteins—CCL2—uterine cancer	3.64e-06	0.000164	CbGpPWpGaD
Cisplatin—GSTT1—Metabolism—PIK3CA—uterine cancer	3.63e-06	0.000164	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	3.59e-06	0.000162	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—AKR1B1—uterine cancer	3.53e-06	0.00016	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—STAR—uterine cancer	3.53e-06	0.00016	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—AKR1C1—uterine cancer	3.52e-06	0.000159	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	3.5e-06	0.000158	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	3.48e-06	0.000157	CbGpPWpGaD
Cisplatin—BCHE—Neuronal System—HRAS—uterine cancer	3.45e-06	0.000156	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	3.37e-06	0.000152	CbGpPWpGaD
Cisplatin—PTGS2—Disease—AKR1C3—uterine cancer	3.36e-06	0.000152	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	3.33e-06	0.000151	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—PTEN—uterine cancer	3.32e-06	0.00015	CbGpPWpGaD
Cisplatin—ABCC5—Disease—ERBB2—uterine cancer	3.31e-06	0.00015	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—STAR—uterine cancer	3.3e-06	0.000149	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—AKR1B1—uterine cancer	3.3e-06	0.000149	CbGpPWpGaD
Cisplatin—PTGS2—Disease—HMGA1—uterine cancer	3.28e-06	0.000148	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	3.26e-06	0.000147	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—RRM2—uterine cancer	3.26e-06	0.000147	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	3.25e-06	0.000147	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—STK11—uterine cancer	3.19e-06	0.000144	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—CYP19A1—uterine cancer	3.19e-06	0.000144	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—EP300—uterine cancer	3.17e-06	0.000143	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—DCN—uterine cancer	3.16e-06	0.000143	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	3.16e-06	0.000143	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—MTHFR—uterine cancer	3.13e-06	0.000142	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—RRM2—uterine cancer	3.13e-06	0.000141	CbGpPWpGaD
Cisplatin—SLC22A2—Neuronal System—HRAS—uterine cancer	3.08e-06	0.000139	CbGpPWpGaD
Cisplatin—ABCC5—Disease—CDKN1B—uterine cancer	3.07e-06	0.000139	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—DCN—uterine cancer	3.04e-06	0.000137	CbGpPWpGaD
Cisplatin—PTGS2—Disease—FBXW7—uterine cancer	3e-06	0.000135	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	2.99e-06	0.000135	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—CYP11A1—uterine cancer	2.98e-06	0.000135	CbGpPWpGaD
Cisplatin—GSTT1—Metabolism—AKT1—uterine cancer	2.97e-06	0.000134	CbGpPWpGaD
Cisplatin—ABCC5—Disease—CTNNB1—uterine cancer	2.9e-06	0.000131	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—STK11—uterine cancer	2.88e-06	0.00013	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—CYP19A1—uterine cancer	2.88e-06	0.00013	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of proteins—CXCL8—uterine cancer	2.87e-06	0.00013	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—CYP11A1—uterine cancer	2.87e-06	0.000129	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of lipids and lipoproteins—EP300—uterine cancer	2.85e-06	0.000129	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—STK11—uterine cancer	2.85e-06	0.000129	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—CYP19A1—uterine cancer	2.85e-06	0.000129	CbGpPWpGaD
Cisplatin—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	2.84e-06	0.000128	CbGpPWpGaD
Cisplatin—ABCC5—Disease—PTEN—uterine cancer	2.82e-06	0.000128	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—PTEN—uterine cancer	2.82e-06	0.000127	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—AKR1C3—uterine cancer	2.82e-06	0.000127	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—POLD1—uterine cancer	2.77e-06	0.000125	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	2.76e-06	0.000125	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—PTEN—uterine cancer	2.75e-06	0.000124	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—AKR1C3—uterine cancer	2.71e-06	0.000122	CbGpPWpGaD
Cisplatin—ABCC5—Disease—EP300—uterine cancer	2.69e-06	0.000122	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—EP300—uterine cancer	2.69e-06	0.000122	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	2.68e-06	0.000121	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of proteins—CTNNB1—uterine cancer	2.65e-06	0.00012	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—EP300—uterine cancer	2.62e-06	0.000118	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—AKR1C1—uterine cancer	2.59e-06	0.000117	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—POLD1—uterine cancer	2.59e-06	0.000117	CbGpPWpGaD
Cisplatin—ABCC5—Disease—NRAS—uterine cancer	2.52e-06	0.000114	CbGpPWpGaD
Cisplatin—XDH—Metabolism—PTEN—uterine cancer	2.47e-06	0.000111	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	2.47e-06	0.000111	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—AKR1C1—uterine cancer	2.42e-06	0.000109	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—MTHFR—uterine cancer	2.39e-06	0.000108	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	2.39e-06	0.000108	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—PTEN—uterine cancer	2.37e-06	0.000107	CbGpPWpGaD
Cisplatin—XDH—Metabolism—EP300—uterine cancer	2.35e-06	0.000106	CbGpPWpGaD
Cisplatin—PTGS2—Disease—CDKN2B—uterine cancer	2.35e-06	0.000106	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—PIK3CA—uterine cancer	2.34e-06	0.000106	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—RRM2—uterine cancer	2.31e-06	0.000104	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—EP300—uterine cancer	2.26e-06	0.000102	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—DCN—uterine cancer	2.24e-06	0.000101	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—CYP19A1—uterine cancer	2.19e-06	9.91e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—STK11—uterine cancer	2.19e-06	9.91e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—KRAS—uterine cancer	2.17e-06	9.79e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—MTHFR—uterine cancer	2.16e-06	9.76e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—RRM2—uterine cancer	2.16e-06	9.75e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—SMAD3—uterine cancer	2.14e-06	9.68e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—MTHFR—uterine cancer	2.14e-06	9.66e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—CYP11A1—uterine cancer	2.11e-06	9.54e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	2.11e-06	9.53e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—CYP19A1—uterine cancer	2.11e-06	9.52e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—STK11—uterine cancer	2.11e-06	9.52e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—DCN—uterine cancer	2.1e-06	9.46e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	2.06e-06	9.3e-05	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—PTEN—uterine cancer	2.05e-06	9.26e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—FGFR2—uterine cancer	2.04e-06	9.23e-05	CbGpPWpGaD
Cisplatin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	2.01e-06	9.1e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—AKR1C3—uterine cancer	2e-06	9.01e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—PIK3CA—uterine cancer	1.99e-06	9e-05	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—PIK3CA—uterine cancer	1.99e-06	8.99e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—CYP11A1—uterine cancer	1.97e-06	8.92e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—MTHFR—uterine cancer	1.97e-06	8.89e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.96e-06	8.87e-05	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—EP300—uterine cancer	1.96e-06	8.83e-05	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—PIK3CA—uterine cancer	1.94e-06	8.76e-05	CbGpPWpGaD
Cisplatin—GSTM1—Metabolism—AKT1—uterine cancer	1.91e-06	8.64e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—AKR1C3—uterine cancer	1.86e-06	8.42e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—HRAS—uterine cancer	1.84e-06	8.32e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—PTEN—uterine cancer	1.74e-06	7.87e-05	CbGpPWpGaD
Cisplatin—XDH—Metabolism—PIK3CA—uterine cancer	1.74e-06	7.86e-05	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—PIK3CA—uterine cancer	1.67e-06	7.54e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—EP300—uterine cancer	1.66e-06	7.51e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—MTHFR—uterine cancer	1.65e-06	7.44e-05	CbGpPWpGaD
Cisplatin—ABCC5—Disease—AKT1—uterine cancer	1.63e-06	7.35e-05	CbGpPWpGaD
Cisplatin—GSTP1—Metabolism—AKT1—uterine cancer	1.63e-06	7.35e-05	CbGpPWpGaD
Cisplatin—NQO1—Metabolism—AKT1—uterine cancer	1.59e-06	7.16e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—MTHFR—uterine cancer	1.58e-06	7.15e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—STK11—uterine cancer	1.56e-06	7.02e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—CYP19A1—uterine cancer	1.56e-06	7.02e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—STK11—uterine cancer	1.45e-06	6.56e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—CYP19A1—uterine cancer	1.45e-06	6.56e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.45e-06	6.56e-05	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—PIK3CA—uterine cancer	1.45e-06	6.53e-05	CbGpPWpGaD
Cisplatin—XDH—Metabolism—AKT1—uterine cancer	1.42e-06	6.42e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.36e-06	6.16e-05	CbGpPWpGaD
Cisplatin—ABCC5—Metabolism—AKT1—uterine cancer	1.36e-06	6.16e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—PTEN—uterine cancer	1.33e-06	6.02e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.3e-06	5.87e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—ERBB2—uterine cancer	1.28e-06	5.8e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—EP300—uterine cancer	1.27e-06	5.74e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—PIK3CA—uterine cancer	1.23e-06	5.56e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—PTEN—uterine cancer	1.2e-06	5.43e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—PTEN—uterine cancer	1.19e-06	5.37e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—CDKN1B—uterine cancer	1.19e-06	5.37e-05	CbGpPWpGaD
Cisplatin—CYP4A11—Metabolism—AKT1—uterine cancer	1.18e-06	5.34e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—MTHFR—uterine cancer	1.17e-06	5.28e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—EP300—uterine cancer	1.15e-06	5.18e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—EP300—uterine cancer	1.13e-06	5.12e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—CTNNB1—uterine cancer	1.12e-06	5.07e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—PTEN—uterine cancer	1.1e-06	4.94e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—MTHFR—uterine cancer	1.09e-06	4.93e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—EP300—uterine cancer	1.04e-06	4.72e-05	CbGpPWpGaD
Cisplatin—ABCC3—Metabolism—AKT1—uterine cancer	1.01e-06	4.54e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—NRAS—uterine cancer	9.77e-07	4.41e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	9.62e-07	4.34e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—PIK3CA—uterine cancer	9.4e-07	4.24e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—PTEN—uterine cancer	9.17e-07	4.14e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—PTEN—uterine cancer	8.81e-07	3.98e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—EP300—uterine cancer	8.75e-07	3.95e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—PIK3CA—uterine cancer	8.48e-07	3.83e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—KRAS—uterine cancer	8.41e-07	3.8e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—EP300—uterine cancer	8.41e-07	3.8e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—PIK3CA—uterine cancer	8.39e-07	3.79e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—PIK3CA—uterine cancer	7.72e-07	3.49e-05	CbGpPWpGaD
Cisplatin—BCHE—Metabolism—AKT1—uterine cancer	7.68e-07	3.47e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—HRAS—uterine cancer	7.15e-07	3.23e-05	CbGpPWpGaD
Cisplatin—ABCG2—Metabolism—AKT1—uterine cancer	6.93e-07	3.13e-05	CbGpPWpGaD
Cisplatin—SLC22A2—Metabolism—AKT1—uterine cancer	6.86e-07	3.1e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—PTEN—uterine cancer	6.5e-07	2.94e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—PIK3CA—uterine cancer	6.47e-07	2.92e-05	CbGpPWpGaD
Cisplatin—PTGS2—Disease—AKT1—uterine cancer	6.31e-07	2.85e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—PIK3CA—uterine cancer	6.22e-07	2.81e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—EP300—uterine cancer	6.2e-07	2.8e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—PTEN—uterine cancer	6.07e-07	2.74e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—EP300—uterine cancer	5.79e-07	2.62e-05	CbGpPWpGaD
Cisplatin—PTGS2—Metabolism—AKT1—uterine cancer	5.29e-07	2.39e-05	CbGpPWpGaD
Cisplatin—CYP2B6—Metabolism—AKT1—uterine cancer	5.08e-07	2.29e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—PIK3CA—uterine cancer	4.59e-07	2.07e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—PIK3CA—uterine cancer	4.28e-07	1.93e-05	CbGpPWpGaD
Cisplatin—ABCB1—Metabolism—AKT1—uterine cancer	3.75e-07	1.69e-05	CbGpPWpGaD
Cisplatin—CYP2C9—Metabolism—AKT1—uterine cancer	3.5e-07	1.58e-05	CbGpPWpGaD
